Human Tissue in Transplantation and Research

Deficiencies and shortfalls in the supply of human organs for transplantation and human tissue for research generate policy dilemmas, stimulate illegitimate commercial activities and prevent the treatment of patients. David Price sets out an integrated legal and policy framework for constructive reform of this area.

---

Deficiencies and shortfalls in the supply of human organs for transplantation and human tissue for research generate policy dilemmas across the world and have often given rise to major and deleterious controversies, such as those relating to organ and tissue retention practices following post-mortem examination. They also create an environment in which illegitimate commercial activities flourish. At the same time, patients are denied the therapy they desperately require and researchers are impeded from carrying out vital work into the causes of, and efficacious treatments for, major illnesses and diseases. David Price sets out a clear and integrated legal and policy framework which emanates from the tissue source but protects the interests of donors and relevant professionals through tailored property entitlements, but without presupposing rights to trade in 'original' materials.